Home » Topics » Regulatory » Patents

Patents
RSS

Kyorin, Sagami report antineoplastic acrylamides

Aug. 16, 1996

Pola claims antisense oligonucleotides for cancer

Aug. 16, 1996

Mitsui Toatsu claims potential antitumor agents

Aug. 16, 1996

MAM-102: antineoplastic protein tyrosine kinase inhibitor

Aug. 16, 1996

Sanofi Winthrop discloses topoisomerase II inhibitors

Aug. 16, 1996

SS Pharm. discloses antitumor platinum complexes

Aug. 16, 1996

Acellular antiBortedella vaccine claimed by Institut Pasteur

Aug. 16, 1996

Oxygermylpropionic acid polymer reported by Sanwa Kagaku

Aug. 16, 1996

CSL discloses HPV vaccine components

Aug. 16, 1996

Kureha discloses MMP-inhibitory esculetin derivatives

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...